U.S. markets open in 2 hours 11 minutes

Aptose Biosciences Inc. (APTO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6100-0.0900 (-3.33%)
At close: 4:00PM EDT
2.6000 -0.01 (-0.38%)
Pre-Market: 06:32AM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/26/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.23
52-Week Change 3-46.64%
S&P500 52-Week Change 334.53%
52 Week High 37.2700
52 Week Low 32.5500
50-Day Moving Average 33.2538
200-Day Moving Average 34.4080

Share Statistics

Avg Vol (3 month) 31.27M
Avg Vol (10 day) 3986.07k
Shares Outstanding 588.94M
Implied Shares Outstanding 6N/A
Float 68.66M
% Held by Insiders 15.07%
% Held by Institutions 160.69%
Shares Short (Jul 14, 2021) 41.68M
Short Ratio (Jul 14, 2021) 41.1
Short % of Float (Jul 14, 2021) 41.91%
Short % of Shares Outstanding (Jul 14, 2021) 41.89%
Shares Short (prior month Jun 14, 2021) 43.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Oct 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.21%
Return on Equity (ttm)-60.96%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -60.04M
Net Income Avi to Common (ttm)-59.94M
Diluted EPS (ttm)-0.7050
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)112.08M
Total Cash Per Share (mrq)1.26
Total Debt (mrq)950k
Total Debt/Equity (mrq)0.87
Current Ratio (mrq)21.26
Book Value Per Share (mrq)1.23

Cash Flow Statement

Operating Cash Flow (ttm)-36.16M
Levered Free Cash Flow (ttm)-13.53M